What the founder of snacks is sought in new longevity investments

Daniel Lubetsky, founder of Snacks Kind Snacks, makes his next bet on longevity.

Lubetsky launched his own venture capital business, Camino Partners, in 2023, three years after sold Kind snacks in March in an agreement that would have been estimated at $ 5 billion.

He no longer has any participation in kind. Now, he is looking for companies to support the sharing philosophy – creating natural and healthy products accessible to consumers, as he described in Business Insider.

With this strategy, Camino Partners has invested in the world fitness channel Barry, joining the main investor Princeton Equity Group.

The company also supported players at the Welllabs medical spa and the home health company Livewell.

These three investments trigger the complete turn of Camino in longevity, said Lubetsky. Camino’s portfolio includes 17 investments in total, most of which are food marks, including the rapid Mediterranean franchise Cava and the regional chain of Hamburger Whataburger.

“There is a overlap between the goods packed by the consumer and the longevity, but we will now focus not only on this overlap but also on other areas of longevity,” said Lubetsky.

Camino capitalizes on an increase in interest in the emerging longevity industry, with scientific progress in longer life emerging alongside technological entrepreneurs like Bryan Johnson spending millions to reverse the aging process.

But Lanning said that Camino did not continue the trend.

“This space certainly has its moment, but we are not here for the moment. We are here for long-term lasting solutions that will really improve people’s lives,” she said.

On the side of nature

Johnson and a large part of the growing crowd of Bros Tech according to his traces do not just want to prolong their lifespan. Instead, they want to raise their bodies with superhuman status and perhaps prevent death entirely.

While Lubetsky says that he is comfortable with a certain degree of technological intervention in longevity, he is more interested in supporting societies on the scale of well-being solutions experienced in fields such as exercise, nutrition and sleep.

“My predilection while we are going to longevity will be not to do things that do not look like what nature wanted,” he said.

Within longevity, Lanning said that Camino envisaged investments in aging, women’s health, digital health and general well-being obtained by these more natural means.

Numerous Camino investments, including new longevity bets, are based on a sum of $ 350 million Lubetsky engaged in the company in 2023. The president of Camino Partners, she Lanning, who heads the company’s investment practice, did not say how many $ 350 million Camino have deployed to date. However, she said that the company was able to invest capital beyond this initial funding to tackle “high conviction opportunities”.

Have a long view

Camino exclusively investments in growth. LANNING said the company focuses on business support with demonstrated traction and efficiency.

In particular, she said that good investment candidates have $ 20 million in income, large gross margins and the ability to draw organically customers by solving a problem on the market.

It is wary of occasional solutions that appear in longevity, such as companies that identify biomarkers with blood tests or other tools, but do not follow care options.

“In the long term, a company that only gives you the identification of problems and does not give you followed solutions will cause consumer fatigue,” she said.

Lanning said she was everything for people like Johnson experimenting with their personal longevity routines. But she and Lubetsky noted that they favor solutions based on evidence in Camino’s portfolio in order to strengthen credibility in a sector often characterized by unleated assertions.

“We want to build a brand where we invest, consumers can trust,” said Lubetsky.